Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

RAD51 135G--C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies, , , , , , , , , and 69 other author(s). American journal of human genetics, 81 (6): 1186–1200 (2007)Formal Concept Analysis for the Identification of Combinatorial Biomarkers in Breast Cancer., , and . ICFCA, volume 4933 of Lecture Notes in Computer Science, page 229-240. Springer, (2008)Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 76 other author(s). American journal of human genetics, 82 (4): 937–948 (2008)No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study, , , , , , , , , and 34 other author(s). Breast cancer research and treatment, 115 (1): 185–192 (2009)Association of death receptor 4 variant (683A C) with ovarian cancer risk in BRCA1 mutation carriers, , , , , , , , , and 6 other author(s). International journal of cancer. Journal international du cancer, 130 (6): 1314–1318 (2012)AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study, , , , , , , , , and 61 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 16 (7): 1416–1421 (2007)Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 127 other author(s). Human molecular genetics, 18 (22): 4442–4456 (2009)Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 58 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19 (11): 2859–2868 (2010)